Literature DB >> 23542874

Iatrogenic Cushing's Syndrome in an Infant.

Rajendra Prasad Namburu1, Karthik T S, Amaresh Reddy P.   

Abstract

A high potency, long acting and/or the extended use of oral corticosteroids, particularly in children, may cause suppression of the hypothalamo-pituitary-adrenal axis. However, the iatrogenic Cushing's syndrome in the infantile age group is rare and only few patients have been reported to date in the literature. Here, we are reporting a case of iatrogenic Cushing's syndrome in a 5-month-old male child, whose parents brought him to the hospital for puffiness of the face and overweight.

Entities:  

Keywords:  Iatrogenic cushing’s syndrome; Infant; Oral corticosteroid

Year:  2013        PMID: 23542874      PMCID: PMC3592310          DOI: 10.7860/JCDR/2013/4529.2766

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  7 in total

1.  Glucocorticoid-induced adrenal insufficiency.

Authors:  A S Krasner
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

2.  Private health in India.

Authors:  Robbie George; Rekha Abraham
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

Review 3.  Safety of inhaled corticosteroids in children.

Authors:  David B Allen
Journal:  Pediatr Pulmonol       Date:  2002-03

4.  Over-the-counter medication and its effects.

Authors:  J Y H Hui; P C Y Woo; S S Lo; J C S Chan
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

5.  Prescribing patterns among medical practitioners in Pune, India.

Authors:  M J Kshirsagar; D Langade; S Patil; P S Patki
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

6.  Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide.

Authors:  S Teelucksingh; B Balkaran; A Ganeshmoorthi; P Arthur
Journal:  Ann Trop Paediatr       Date:  2002-03

7.  An infantile Cushing syndrome due to misuse of topical steroid.

Authors:  Zeynep Siklar; Ilknur Bostanci; Ozlem Atli; Yildiz Dallar
Journal:  Pediatr Dermatol       Date:  2004 Sep-Oct       Impact factor: 1.588

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.